par Evdokimov, Nikolai M;Van Slambrouck, Séverine;Heffeter, Petra;Tu, Lee;Le Calve, Benjamin ;Lamoral-Theys, Delphine ;Hooten, Carla J;Uglinskii, Pavel Y;Rogelj, Snezna;Kiss, Robert ;Steelant, Wim F A;Berger, Walter;Yang, Jeremy J;Bologa, Cristian G;Kornienko, Alexander;Magedov, Igor V
Référence Journal of medicinal chemistry, 54, 7, page (2012-2021)
Publication Publié, 2011-04
Référence Journal of medicinal chemistry, 54, 7, page (2012-2021)
Publication Publié, 2011-04
Article révisé par les pairs
Titre: |
|
Auteur: | Evdokimov, Nikolai M; Van Slambrouck, Séverine; Heffeter, Petra; Tu, Lee; Le Calve, Benjamin; Lamoral-Theys, Delphine; Hooten, Carla J; Uglinskii, Pavel Y; Rogelj, Snezna; Kiss, Robert; Steelant, Wim F A; Berger, Walter; Yang, Jeremy J; Bologa, Cristian G; Kornienko, Alexander; Magedov, Igor V |
Informations sur la publication: | Journal of medicinal chemistry, 54, 7, page (2012-2021) |
Statut de publication: | Publié, 2011-04 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antineoplastic Agents -- chemical synthesis -- chemistry -- pharmacology |
Biological Agents -- chemical synthesis -- chemistry -- pharmacology | |
Cell Line, Tumor | |
Cell Proliferation -- drug effects | |
DNA Topoisomerases, Type I -- metabolism | |
DNA Topoisomerases, Type II -- metabolism | |
Humans | |
Inhibitory Concentration 50 | |
Topoisomerase II Inhibitors -- chemical synthesis -- chemistry -- pharmacology | |
Uracil -- chemical synthesis -- chemistry -- pharmacology | |
Note générale: | Journal Article |
Research Support, N.I.H., Extramural | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0022-2623 |
info:doi/10.1021/jm1009428 | |
info:scp/79953775167 | |
info:pmid/21388138 |